Chardan Capital Markets Starts Eyegate Pharmaceuticals (EYEG) at Buy
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.34 +0.09%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Chardan Capital Markets initiated coverage on Eyegate Pharmaceuticals (NASDAQ: EYEG) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Eyegate Pharmaceuticals click here. For more ratings news on Eyegate Pharmaceuticals click here.
Shares of Eyegate Pharmaceuticals closed at $2.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- Scotiabank Starts Robinhood Markets (HOOD) at Sector Outperform
- H.C. Wainwright Starts Eagle Nuclear Energy (NUCL) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
